GlassScriptPhysician profile
Brian Sheng Ting
NPI 1801117684
$20,508.13
in general payments reported to CMS, 2019-2025
13 companies · $1,701 in 2025
The $1,701 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,965 · 2020: $1,102 · 2021: $802 · 2022: $2,569 · 2023: $3,451 · 2024: $7,919 · 2025: $1,701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,500 · Travel and Lodging: $4,684 · Food and Beverage: $1,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,500.00 |
| Travel and Lodging | $4,683.91 |
| Food and Beverage | $1,886.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $9,844.55 | 2023-2025 | |
| Treace Medical Concepts, INC. | $5,428.34 | 2020-2025 | |
| Medical Device Business Services, INC. | $1,791.97 | 2019-2023 | |
| Stryker Corporation | $1,559.59 | 2022-2025 | Prostep, Salvation, Prostep Mica |
| Amniox Medical, INC. | $961.85 | 2019 | |
| Biotissue Holdings INC. | $269.48 | 2019 | |
| Depuy Synthes Sales INC. | $224.17 | 2019-2022 | |
| Kerecis Limited | $157.33 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Gilead Sciences, INC. | $142.83 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $51.36 | 2019 | |
| Davol INC. | $31.94 | 2024 | Arista Ah Flexitip |
| Abbott Laboratories | $27.32 | 2022-2023 | Proclaim |
| Averitas Pharma INC. | $17.40 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.